ADVERUM BIOTECHNOLOGIES
Adverum Biotechnologies is a clinical-stage company that aims to establish gene therapy as a new standard of care for a number of highly prevalent ocular diseases with the aspiration of developing functional cures for these diseases to restore vision and prevent blindness. Their services include gene therapy, biotechnology, rare diseases, ophthalmology, and retina.
ADVERUM BIOTECHNOLOGIES
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2006-01-01
Address:
Menlo Park, California, United States
Country:
United States
Website Url:
http://www.adverum.com
Total Employee:
101+
Status:
Active
Contact:
+1 650 272 6269
Email Addresses:
[email protected]
Total Funding:
648.47 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Rock Springs Capital
Rock Springs Capital investment in Series B - Adverum Biotechnologies
Deerfield
Deerfield investment in Series B - Adverum Biotechnologies
Venrock
Venrock investment in Series B - Adverum Biotechnologies
Adage Capital Management
Adage Capital Management investment in Series B - Adverum Biotechnologies
Redmile Group
Redmile Group investment in Series B - Adverum Biotechnologies
Sabby Capital
Sabby Capital investment in Series B - Adverum Biotechnologies
Key Employee Changes
Official Site Inspections
http://www.adverum.com Semrush global rank: 1.79 M Semrush visits lastest month: 12.85 K
- Host name: 134.171.203.35.bc.googleusercontent.com
- IP address: 35.203.171.134
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Adverum Biotechnologies"
About Us - Adverum Biotechnologies
Adverum Biotechnologies is a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases with the aspiration of developing …See details»
Adverum Biotechnologies - Wikipedia
Adverum Biotechnologies, Inc., formerly known as Avalanche Biotechnologies, is a publicly traded clinical stage gene therapy company located in Redwood City, California. The company is targeting unmet medical needs for serious ocular and rare diseases, including wet age-related macular degeneration (wet AMD). See details»
Adverum Biotechnologies - Crunchbase Company Profile & Funding
Adverum Biotechnologies is a clinical-stage company that aims to establish gene therapy as a new standard of care for a number of highly prevalent ocular diseases with the aspiration of …See details»
Adverum Biotechnologies - LinkedIn
Adverum Biotechnologies (NASDAQ: ADVM) is a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases with the aspiration of ...See details»
Sustainability - Adverum Biotechnologies
Employees at all levels of the organization have access to Adverum University, learning forums, work rotations, and management certificate programs. Our comprehensive training and development programs aim to cover topics from …See details»
Adverum Biotech - The Org
Adverum Biotechnologies (Nasdaq: ADVM) is a clinical-stage gene therapy company targeting unmet medical needs for serious ocular and rare diseases. Adverum is evaluating its novel gene therapy candidate, ADVM-022, as a one …See details»
Adverum Biotechnologies, Inc. - Events & Presentations
We are driven to establish gene therapy as a new standard of care for the leading causes of vision loss.See details»
Adverum Biotechnologies, Inc. - Governance
The Board of Directors of Adverum Biotechnologies, Inc. sets high standards for the Company's employees, officers and directors. Implicit in this philosophy is the importance of sound …See details»
Adverum Biotechnologies, Inc. - AnnualReports.com
Adverum is a gene therapy company advancing novel medicines that can offer life-changing benefits to patients living with serious rare and ocular diseases. Adverum has a robust pipeline …See details»
Adverum Biotechnologies, Inc. - Investor Relations
Adverum Biotechnologies is a clinical-stage company that aims to establish gene therapy as a new standard of care for a number of highly prevalent ocular diseases with the aspiration of …See details»
Adverum Biotechnologies - Funding, Financials, Valuation
Adverum Biotechnologies is a gene therapy company that focuses on developing medicines that can offer therapeutic benefits to patients. Search Crunchbase. ... How much funding has this …See details»
Adverum Announces Changes to Management Team - Yahoo …
Jun 24, 2021 -- Christopher J. DeRespino appointed acting CFO -- -- Peter Soparkar appointed COO -- -- Leone Patterson departs as president and CFO after five years of service -- …See details»
Our Technology - Adverum Biotechnologies
Adverum explores new ways to deliver proteins by gene therapy to the eye. Gene therapy is a decades old field that focuses on delivery of genetic material to specific cells in the body to …See details»
Adverum Files Investor Presentation Highlighting Significant …
Apr 22, 2021 --Adverum Biotechnologies, Inc., a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced that it has filed a new …See details»
Adverum Biotechnologies, Inc. - Adverum Biotechnologies …
Aug 21, 2023 Dr. Ramelmeier has more than 30 years of experience in drug development and clinical and commercial chemistry, manufacturing and controls (CMC), including gene and cell …See details»
News & Publications - Adverum Biotechnologies
Aug 10, 2024 Adverum Biotechnologies Reports Additional Clinical Data from First Cohort of OPTIC Phase 1 Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMD at the Atlantic …See details»
Adverum Biotechnologies, Inc. (ADVM) - Yahoo Finance
Adverum Biotechnologies Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) REDWOOD CITY, Calif., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, …See details»
Join The Team - Adverum Biotechnologies
As a resilient learning organization, we empower and encourage our employees to reach their full potential by offering resources and opportunities to learn and grow. ... Adverum always lists all …See details»
Pipeline - Adverum Biotechnologies
Adverum’s promising pipeline moves us ever closer to establishing ocular gene therapy as a new standard of care for debilitating ocular diseases. Advancing Ocular Gene Therapy …See details»